Following Its 23rd Cancer Center Summit, the Cancer Center Informatics Society Issues Statement of Support for The American Center for Cures and Bipartisan Efforts to Accelerate Prevention and Cures for Major Diseases

Los Angeles, CA — The Cancer Center Informatics Society (Ci4CC), the leading international data science and clinical informatics organization dedicated to advancing AI and translational research in oncology, today announced its strong endorsement of The American Center for Cures (ACC) — a bold, bipartisan initiative committed to preventing and curing major diseases, including cancer.

The statement of support follows Ci4CC’s 23rd Cancer Center Summit, which convened leaders in oncology, data science, and AI innovation. Ci4CC reaffirmed the urgent need for national collaboration and visionary leadership to drive real-world, equitable impact. The Society emphasized the transformative role of AI, data science, and cross-sector coordination in reshaping cancer research, care delivery, and public health.

“An ambitious vision with the potential for a profound impact,” said Dr. Steven T. Rosen, renowned oncologist and Executive Vice President and Director Emeritus of City of Hope Comprehensive Cancer Center.

“As both a researcher and healthcare advocate, I’ve seen firsthand how devastating and complex cancer can be for patients and their families,” said Sorena Nadaf-Rahrov, President and CEO of Ci4CC. “Cancer is emblematic of the broader crisis we face with chronic and life-threatening diseases — many of which remain underserved. The economic burden of cancer exceeds $200 billion annually in the U.S. alone, factoring in both direct medical costs and lost productivity. That’s why national frameworks like The American Center for Cures are essential. We must foster innovation, connect institutions, and accelerate real solutions for patients.”

Lou Weisbach, founder and leader of The American Center for Cures, added: . We deeply appreciate the endorsement of the Cancer Center Informatics Society. AI and data are at the center of our commitment to bring together the five business essentials necessary to prevent and cure disease once and for all: full funding, dynamic proven leadership, process, accountability, and a sense of urgency. By allocating $108 billion to the AI and data entity within ACC, we recognize the critical role your industry plays in helping us cross the finish line — on behalf of all patients and their families.”

Cancer remains one of the most urgent public health challenges of our time. According to Cancer Statistics 2025, recently published by the American Cancer Society:

• An estimated 2 million new cancer cases will be diagnosed in the U.S. in 2025
• Over 618,000 cancer-related deaths are projected
• Stark racial and ethnic disparities in outcomes continue, especially among underserved populations

Ci4CC’s work has consistently demonstrated that AI and data science are essential to accelerating innovation in early detection, precision oncology, and clinical trial optimization — yet widespread adoption remains elusive.

Nadaf-Rahrov concluded:

“The mission of The American Center for Cures aligns with Ci4CC’s commitment to transforming oncology through the power of data and AI. We are proud to support this national initiative — one that holds real promise for delivering faster, better outcomes for all.”

For more information, visit

• Ci4CC ACC Initiative Working Group: https://www.ci4cc.org/american-center-for-cures
• American Center for Cures:  https://theamericancenterforcures.org.